aspirin has been researched along with cyclosporine in 63 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 23 (36.51) | 18.2507 |
2000's | 17 (26.98) | 29.6817 |
2010's | 22 (34.92) | 24.3611 |
2020's | 1 (1.59) | 2.80 |
Authors | Studies |
---|---|
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Deaton, DW; Gamliel, H; Glick, DB; Karp, RB; Liddicoat, JR; Perelman, MJ; Rocco, F; Stephens, JK; Watkins, CW | 1 |
Baeza, E; Boulard, C; Delers, F; Poitou, I | 1 |
Biban, C; Siliprandi, D; Siliprandi, N; Tassani, V; Toninello, A | 1 |
Shoenfeld, Y | 1 |
Adams, KE; Brown, PA; Heys, SD; Whiting, PH | 1 |
Bergman, RT; Brockbank, KG; Gloviczki, P; Miller, VM | 1 |
Gaber, M; Jähnchen, E; Johnston, A; Kovarik, JM; Mueller, EA | 1 |
Hanawa, H; Izumi, T; Kodama, M; Masani, F; Shibata, A; Zhang, S | 1 |
Evancho, MM; Hirko, MK; McShannic, JR; Schmidt, SP; Sharp, WV; Siebert, JD; Sims, RL | 1 |
Miotto, G; Pizzo, P; Rizzuto, R; Siliprandi, N; Venerando, R | 1 |
Lemasters, JJ; Trost, LC | 1 |
Beauparlant, P; Hiscott, J | 1 |
Cai, W; Foulkes, JG; Hu, L | 1 |
Brigham, KM; Jones, P; Murphy, P; Seymour, RA; Thomason, JM | 1 |
Ciccarelli, A; de Crescenzo, G; de Paulis, A; Marinò, D; Marinò, I; Marone, G | 1 |
O'Neill, EA | 1 |
Burgers, SA; van Vloten, WA | 1 |
Al-Nasser, IA | 1 |
Amberger, A; Grubeck-Loebenstein, B; Hala, M; Metzler, B; Saurwein-Teissl, M; Wick, G; Xu, Q | 1 |
Braun-Dullaeus, RC; Feussner, M; Grimminger, F; Haberbosch, W; Hopmann, H; Kraemer, HJ; Tillmanns, H; Walker, G | 1 |
Ahrén, B; Al Rayyes, O; Florén, CH | 1 |
Carrier, M; Daly, P; Davies, R; Gudas, V; Kostuk, W; Latter, D; Rivard, M; Sullivan, J; Teo, K; White, M | 1 |
Jankowska, R; Kraus-Filarska, M; Małolepszy, J; Nadobna, G; Nowak, I; Zak-Nejmark, T | 1 |
Gray, DW; Morris, PJ; Nargund, V; Robertson, AJ | 1 |
Chatila, T; Kim, J; Raman, V; Sharkey, A | 1 |
Levi, M; Moons, AH; Peters, RJ | 1 |
Furness, PN; Murphy, GJ; Nicholson, ML; Sandford, RS; Waller, JR | 1 |
Orsoni, JG; Pellistri, I; Rama, P; Vincenti, V; Zavota, L | 1 |
Airò, P; Biggioggero, M; Borghi, O; Cimaz, R; Meregalli, E; Meroni, PL; Motta, M; Tincani, A | 1 |
Freeman, AF; Shulman, ST | 1 |
Centeno, J; Crovetto, M; Solano, D | 1 |
Bischoff, SC; Fleig, W; Reissmann, A | 1 |
Chan, FK; Leong, RW | 1 |
Beaugerie, L; Cosnes, J; Daniel, F; Marteau, P; Seksik, P | 1 |
Takahashi, R | 1 |
Charkoftaki, G; Kytariolos, J; Macheras, P | 1 |
Dönmez, O; Durmaz, O | 1 |
Amano, Y; Fukuba, N; Ishihara, S; Kinoshita, Y; Kusunoki, R; Mishima, Y; Moriyama, I; Murakawa, Y; Oka, A; Okada, M; Oshima, N; Sato, M; Sato, S; Sumita, Y; Tada, Y; Yuki, T | 1 |
Barreiro-de-Acosta, M; Campos-Franco, J; Losada-Ares, L; Pérez-Pampín, E | 1 |
Burgner, D; Kuijpers, TW; Kuipers, IM; Tacke, CE | 1 |
Enya, T; Izu, A; Miyazawa, T; Nishi, H; Okada, M; Sugimoto, K; Takemura, T | 1 |
Frank, J; Podszun, M | 1 |
Anelli, MG; Cacciapaglia, F; Covelli, M; Iannone, F; Lapadula, G; Rinaldi, A; Scioscia, C; Serafino, L | 1 |
Aoyagi, R; Ebata, R; Hamada, H; Hanaoka, H; Hata, A; Nagashima, K; Onouchi, Y; Sato, Y; Suzuki, H; Terai, M; Terauchi, M | 1 |
Katagiri, K | 1 |
Archer, T; Mackin, A; Press, S; Thomason, J; Wills, R | 1 |
Archer, TM; Fellman, C; Haraschak, J; Kummari, E; Mackin, A; Pinchuk, L; Stokes, JV; Thomason, J; Wills, R | 1 |
Gámez-González, LB; Hamada, H; Honda, T; Murata, C; Yamazaki-Nakashimada, MA; Yasukawa, K | 1 |
Hoshina, T; Ito, T; Kusuhara, K; Taku, K | 1 |
12 review(s) available for aspirin and cyclosporine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Immunosuppression of experimental systemic lupus erythematosus and antiphospholipid syndrome.
Topics: Adjuvants, Immunologic; Androgens; Animals; Antibodies, Anti-Idiotypic; Antiphospholipid Syndrome; Aspirin; Bone Marrow Transplantation; Bromocriptine; Cyclosporine; Disease Models, Animal; Estrogens; Ethylenes; Heparin; Hydroxyquinolines; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Lymphocyte Transfusion; Mice; T-Lymphocytes, Regulatory | 1994 |
Biological and biochemical inhibitors of the NF-kappa B/Rel proteins and cytokine synthesis.
Topics: Animals; Antioxidants; Aspirin; Cyclosporine; Cytokines; Dinoprostone; Forecasting; Glucocorticoids; Humans; Immunosuppressive Agents; Mutation; NF-kappa B; Nitric Oxide; Oncogene Proteins v-rel; Phosphorylation; Protease Inhibitors; Proto-Oncogene Proteins; Retroviridae Proteins, Oncogenic; Tacrolimus; Transcription Factor RelB; Transcription Factors | 1996 |
Transcription-modulating drugs: mechanism and selectivity.
Topics: Animals; Anti-Inflammatory Agents; Aspirin; Cyclosporine; Drug Design; Estrogen Antagonists; Humans; Hypoglycemic Agents; Immunosuppressive Agents; Polyenes; Sirolimus; Tacrolimus; Thiazoles; Transcription, Genetic | 1996 |
Tissue factor and coronary artery disease.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Anticoagulants; Arginine; Aspirin; Coronary Artery Disease; Coronary Thrombosis; Cyclosporine; Endothelium, Vascular; Factor VIIa; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Hypolipidemic Agents; Leukocytes, Mononuclear; Muscle, Smooth, Vascular; Recombinant Proteins; Thrombin; Thromboplastin | 2002 |
Refractory Kawasaki disease.
Topics: Anti-Inflammatory Agents; Aspirin; Cyclosporine; Drug Therapy, Combination; Fever; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Recurrence | 2004 |
Drug-induced side effects affecting the gastrointestinal tract.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bone Density Conservation Agents; Colitis; Colon; Cyclosporine; Diphosphonates; Duodenal Obstruction; Duodenal Ulcer; Esophagitis; Esophagus; Gingival Hyperplasia; Humans; Immunosuppressive Agents; Intestine, Small; Mouth; Stomach Ulcer | 2006 |
[Refractory proctitis].
Topics: Administration, Oral; Adrenal Cortex Hormones; Algorithms; Anesthetics, Local; Antibodies, Monoclonal; Aspirin; Azathioprine; Biopsy; Cyclosporine; Drug Therapy, Combination; Escherichia coli; Forecasting; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Lidocaine; Methotrexate; Nicotine; Patient Compliance; Probiotics; Proctitis; Randomized Controlled Trials as Topic; Rectum; Suppositories; Time Factors | 2007 |
[Drug-induced thrombotic thrombocytopenic purpura].
Topics: Antirheumatic Agents; Aspirin; Cyclosporine; Diagnosis, Differential; Humans; Immunosuppressive Agents; Penicillamine; Plasma; Plasma Exchange; Platelet Aggregation Inhibitors; Prognosis; Purpura, Thrombotic Thrombocytopenic; Ticlopidine | 2007 |
Rare case of Takayasu's arteritis associated with Crohn's disease.
Topics: Adolescent; Adult; Aortic Valve Insufficiency; Aspirin; Coronary Artery Bypass; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Female; Heart Valve Prosthesis Implantation; Humans; Magnetic Resonance Angiography; Prednisolone; Takayasu Arteritis; Tomography, X-Ray Computed; Warfarin; Young Adult | 2011 |
Management of acute and refractory Kawasaki disease.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Murine-Derived; Aspirin; Chemotherapy, Adjuvant; Coronary Aneurysm; Cyclosporine; Enzyme Inhibitors; Humans; Immunoglobulins, Intravenous; Methotrexate; Mucocutaneous Lymph Node Syndrome; Rituximab; Tumor Necrosis Factor-alpha | 2012 |
Vitamin E-drug interactions: molecular basis and clinical relevance.
Topics: Animals; Aspirin; Cyclosporine; Dietary Supplements; Dose-Response Relationship, Drug; Drug Interactions; Humans; Tamoxifen; Vitamin E; Warfarin | 2014 |
5 trial(s) available for aspirin and cyclosporine
Article | Year |
---|---|
Pharmacokinetics of cyclosporine and steady-state aspirin during coadministration.
Topics: Adult; Aspirin; Cyclosporine; Drug Interactions; Half-Life; Humans; Male; Metabolic Clearance Rate | 1993 |
Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis.
Topics: Adult; Analysis of Variance; Aspirin; Cyclosporine; Extracellular Matrix; Female; Fibrosis; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Nifedipine; Prednisolone; Prospective Studies; Tacrolimus; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2003 |
Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
Topics: Adalimumab; Adrenal Cortex Hormones; Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Certolizumab Pegol; Cholesterol; Cyclosporine; Drug Therapy, Combination; Etanercept; Female; Humans; Hydroxychloroquine; Immunoglobulin Fab Fragments; Immunoglobulin G; Infliximab; Lipid Metabolism; Male; Methotrexate; Middle Aged; Polyethylene Glycols; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Sulfasalazine; Treatment Outcome; Triglycerides; Tumor Necrosis Factor-alpha | 2014 |
Study protocol for a phase III multicentre, randomised, open-label, blinded-end point trial to evaluate the efficacy and safety of immunoglobulin plus cyclosporin A in patients with severe Kawasaki disease (KAICA Trial).
Topics: Aspirin; Calcineurin Inhibitors; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Infant; Japan; Male; Mucocutaneous Lymph Node Syndrome; Proportional Hazards Models; Research Design; Treatment Outcome | 2015 |
The Effects of Cyclosporine and Aspirin on Platelet Function in Normal Dogs.
Topics: Animals; Aspirin; Blood Platelets; Cross-Over Studies; Cyclosporine; Dogs; Immunosuppressive Agents; Nephelometry and Turbidimetry; Platelet Aggregation; Platelet Aggregation Inhibitors | 2016 |
46 other study(ies) available for aspirin and cyclosporine
Article | Year |
---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Evaluation of cryopreserved allograft venous conduits in dogs.
Topics: Animals; Anti-Bacterial Agents; Aspirin; Blood Vessel Prosthesis; Cryopreservation; Cyclosporine; Dogs; Evaluation Studies as Topic; Forelimb; Graft Rejection; Jugular Veins; Male; Microscopy, Electron, Scanning; Transplantation, Homologous; Vascular Patency; Veins | 1992 |
Influence of anti-inflammatory treatments on experimental infection of rats with Fasciola hepatica: changes in serum levels of inflammatory markers during the early stages of fasciolosis.
Topics: Acute-Phase Proteins; Analysis of Variance; Animals; Antibodies, Helminth; Antibody Formation; Antigens, Helminth; Aspirin; Biomarkers; Complement C3; Cyclosporine; Dexamethasone; Fasciola hepatica; Fascioliasis; Female; Fibrinogen; Indomethacin; Inflammation; Leukocyte Count; Male; Platelet Count; Rats; Rats, Wistar; Time Factors | 1994 |
The alterations in the energy linked properties induced in rat liver mitochondria by acetylsalicylate are prevented by cyclosporin A or Mg2+.
Topics: Animals; Aspirin; Calcium; Cyclosporine; Magnesium; Membrane Potentials; Mitochondria, Liver; Permeability; Rats; Sucrose | 1995 |
Alleviation of experimental cyclosporin A nephrotoxicity by low dose aspirin in the rat.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Creatinine; Cyclosporine; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Thromboxane A2; Urea | 1993 |
Cryopreserved venous allografts: effects of immunosuppression and antiplatelet therapy on patency and function.
Topics: Animals; Aspirin; Cryopreservation; Cyclosporine; Dogs; Endothelium, Vascular; Femoral Artery; Male; Muscle, Smooth, Vascular; Platelet Adhesiveness; Saphenous Vein; Time Factors; Transplantation, Homologous; Vascular Patency | 1993 |
Effects of cyclosporine, prednisolone and aspirin on rat autoimmune giant cell myocarditis.
Topics: Animals; Antibodies; Antibody Formation; Aspirin; Autoimmune Diseases; Cyclosporine; Giant Cells; Male; Myocarditis; Myocardium; Myosins; Prednisolone; Rats; Rats, Inbred Lew; Treatment Outcome | 1993 |
Pharmacologic modulation of intimal hyperplasia in canine vein interposition grafts.
Topics: Animals; Aspirin; Blood Vessel Prosthesis; Carotid Arteries; Cilazapril; Cyclosporine; Dogs; Female; Femoral Artery; Graft Occlusion, Vascular; Hyperplasia; Jugular Veins; Male; Time Factors; Tunica Intima; Vascular Patency | 1993 |
Mitochondrial alterations induced by aspirin in rat hepatocytes expressing mitochondrially targeted green fluorescent protein (mtGFP).
Topics: Animals; Aspirin; Cell Survival; Cells, Cultured; Cyclosporine; Fluorescent Dyes; Green Fluorescent Proteins; Luminescent Proteins; Male; Mitochondria, Liver; Rats; Rats, Wistar; Rhodamine 123; Rhodamines; Transfection; Urea | 1996 |
The mitochondrial permeability transition: a new pathophysiological mechanism for Reye's syndrome and toxic liver injury.
Topics: Animals; Aspirin; Carboxylic Acids; Chemical and Drug Induced Liver Injury; Cyclosporine; Male; Membrane Potentials; Mitochondria, Liver; Mitochondrial Swelling; Rats; Rats, Sprague-Dawley; Reye Syndrome; Ruthenium Red; Structure-Activity Relationship; Valproic Acid | 1996 |
Aspirin-induced post-gingivectomy haemorrhage: a timely reminder.
Topics: Adult; Aspirin; Cyclosporine; Dental Care for Chronically Ill; Gingival Hypertrophy; Gingivectomy; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Oral Hemorrhage; Platelet Aggregation; Platelet Transfusion; Postoperative Hemorrhage | 1997 |
Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs.
Topics: Adenosine; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Chymases; Cyclosporine; Diclofenac; Histamine Release; Humans; Immunoglobulin E; Immunosuppressive Agents; Leukotriene C4; Mast Cells; Methotrexate; Middle Aged; Polyenes; Prostaglandins D; Rheumatic Diseases; Serine Endopeptidases; Sirolimus; Substance P; Sulfonamides; Synovial Membrane; Tacrolimus; Tryptases | 1997 |
A new target for aspirin.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Rheumatoid; Aspirin; Calcium-Calmodulin-Dependent Protein Kinases; Cyclooxygenase Inhibitors; Cyclosporine; Dose-Response Relationship, Drug; Enzyme Inhibitors; I-kappa B Kinase; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Prednisolone; Protein Serine-Threonine Kinases | 1998 |
[Findings in children with psoriasis].
Topics: Adolescent; Adrenal Cortex Hormones; Anthralin; Anti-Inflammatory Agents; Aspirin; Calcitriol; Child; Cyclosporine; Dermatologic Agents; Female; Genetic Predisposition to Disease; Humans; Male; Phototherapy; Psoriasis; Retrospective Studies; Tars; Treatment Outcome; Tretinoin | 1999 |
Salicylate-induced kidney mitochondrial permeability transition is prevented by cyclosporin A.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Calcium; Cyclosporine; Immunosuppressive Agents; In Vitro Techniques; Kidney; Male; Mitochondria; Mitochondrial Swelling; Permeability; Rats; Rats, Sprague-Dawley; Salicylic Acid | 1999 |
Suppressive effects of anti-inflammatory agents on human endothelial cell activation and induction of heat shock proteins.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cell Division; Cells, Cultured; Chaperonin 60; Chemokine CCL2; Cyclosporine; E-Selectin; Endothelium, Vascular; Female; Heat-Shock Proteins; HSP70 Heat-Shock Proteins; Humans; Immunosuppressive Agents; Indomethacin; Intercellular Adhesion Molecule-1; Lymphocytes; Male; NF-kappa B; Transcription Factors; Vascular Cell Adhesion Molecule-1 | 1999 |
Cyclosporine-induced coronary artery constriction--dissociation between thromboxane release and coronary vasospasm.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Pressure; Calcium Channel Blockers; Coronary Circulation; Coronary Vasospasm; Coronary Vessels; Cyclooxygenase Inhibitors; Cyclosporine; Endothelium, Vascular; Heart; Heart Rate; Immunosuppressive Agents; Male; Myocardial Contraction; Myocardium; Nifedipine; Nitric Oxide Donors; Nitroglycerin; Pharmaceutical Vehicles; Polyethylene Glycols; Prostanoic Acids; Rats; Rats, Wistar; Receptors, Thromboxane; Thromboxane B2; Vasoconstrictor Agents; Vasodilator Agents | 1999 |
Enhancement of low density lipoprotein catabolism by non-steroidal anti-inflammatory drugs in cultured HepG2 cells.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclosporine; Drug Interactions; Flufenamic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indomethacin; Lipoproteins, LDL; Receptors, LDL; RNA, Messenger; Tumor Cells, Cultured | 1999 |
The Canadian Study of Cardiac Transplantation. Atherosclerosis. Investigators of the CASCADE Study.
Topics: Adult; Antihypertensive Agents; Arteriosclerosis; Aspirin; Cardiovascular Agents; Cyclosporine; Cytomegalovirus Infections; Diltiazem; Female; Follow-Up Studies; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Ischemia; Postoperative Care; Postoperative Complications | 1999 |
[Effects of anti-inflammatory drugs on adhesion and migration of lymphocytes].
Topics: Adult; Anti-Inflammatory Agents; Antigens, CD; Aspirin; Cell Adhesion; Cell Movement; Cells, Cultured; Cyclosporine; Dose-Response Relationship, Drug; Female; Humans; Hydrocortisone; Lymphocytes; Male; Methotrexate; Reference Values; Transforming Growth Factor beta | 1999 |
Low dose aspirin as prophylaxis against renal-vein thrombosis in renal-transplant recipients.
Topics: Adult; Aged; Aspirin; Cadaver; Cyclosporine; Databases as Topic; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Living Donors; Middle Aged; Postoperative Complications; Ranitidine; Renal Veins; Retrospective Studies; Time Factors; Tissue Donors; Treatment Failure; Venous Thrombosis | 2000 |
Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Methylprednisolone; Mucocutaneous Lymph Node Syndrome; Recurrence | 2001 |
Cogan syndrome in children: early diagnosis and treatment is critical to prognosis.
Topics: Amblyopia; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Autoimmune Diseases; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Fludrocortisone; Hearing Loss, Sensorineural; Humans; Immunosuppressive Agents; Keratitis; Male; Methotrexate; Prognosis; Syndrome; Vasculitis; Vision, Low | 2004 |
Alterations in the immune system of children from mothers treated with immunosuppressive agents during pregnancy.
Topics: Adult; Aspirin; Autoimmune Diseases; Azathioprine; Cyclosporine; Dexamethasone; Female; Hemoglobins; Hepatitis Antibodies; Hepatitis B Vaccines; Humans; Hydroxychloroquine; Immune System; Immunoglobulin G; Immunoglobulins; Immunosuppressive Agents; Infant; Infant, Newborn; Leukocyte Count; Lymphocyte Count; Male; Platelet Count; Prednisone; Pregnancy; Vaccination | 2004 |
[Recurrent polychondritis: apropos of a case].
Topics: Aspirin; Autoimmune Diseases; Azathioprine; Biopsy; Carcinoma, Squamous Cell; Conjunctivitis; Cyclosporine; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Facial Neoplasms; Female; Fever; Hearing Disorders; Humans; Immunosuppressive Agents; Middle Aged; Nasal Obstruction; Otitis Media with Effusion; Polychondritis, Relapsing; Prednisone; Scleritis | 2003 |
[Ulcerative colitis. Acute episode].
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azathioprine; Colitis, Ulcerative; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Mesalamine; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors | 2004 |
Novel milk-based oral formulations: proof of concept.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Buffers; Chemistry, Pharmaceutical; Cyclosporine; Danazol; Ethanol; Humans; Male; Meloxicam; Milk; Solubility; Thiazines; Thiazoles | 2010 |
Calcinosis cutis universalis with pediatric systemic lupus erythematosus.
Topics: Administration, Oral; Antiphospholipid Syndrome; Aspirin; Calcinosis; Child; Cyclosporine; Dermatologic Agents; Diltiazem; Drug Therapy, Combination; Enoxaparin; Fibrinolytic Agents; Glomerulonephritis, Membranoproliferative; Glucocorticoids; Humans; Lupus Erythematosus, Systemic; Male; Skin Ulcer; Treatment Outcome | 2010 |
Avascular necrosis of the knees and ulcerative colitis.
Topics: Adrenal Cortex Hormones; Adult; Aspirin; Cholecalciferol; Colitis, Ulcerative; Cyclosporine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Knee Joint; Male; Mesalamine; Osteonecrosis; Pain; Platelet Aggregation Inhibitors; Radiography; Simvastatin; Vitamins | 2011 |
Childhood Cogan syndrome with aortitis and anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Topics: Adolescent; Adult; Antibodies, Antineutrophil Cytoplasmic; Antirheumatic Agents; Aortitis; Aspirin; Cataract; Cogan Syndrome; Cyclosporine; Disease Progression; Glomerulonephritis; Hearing Loss, Sensorineural; Humans; Kidney; Kidney Function Tests; Magnetic Resonance Angiography; Male; Prednisolone | 2014 |
Aspirin and loxoprofen relieve refractory pruritus in patients with prurigo nodularis.
Topics: Administration, Cutaneous; Administration, Oral; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclosporine; Dermatologic Agents; Drug Therapy, Combination; Glucocorticoids; Headache; Histamine Antagonists; Humans; Incidental Findings; Leg Injuries; Male; Middle Aged; Phenylpropionates; Prurigo; Pruritus; Roxithromycin; Treatment Failure; Visual Analog Scale | 2016 |
In vivo effects of aspirin and cyclosporine on regulatory T cells and T-cell cytokine production in healthy dogs.
Topics: Administration, Oral; Anemia, Hemolytic; Animals; Aspirin; Cross-Over Studies; Cyclosporine; Dogs; Flow Cytometry; Immunity, Cellular; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Lymphocyte Activation; T-Lymphocytes, Regulatory | 2018 |
IgG levels in Kawasaki disease and its association with clinical outcomes.
Topics: Aspirin; Child; Child, Preschool; Cyclosporine; Female; Humans; Immunoglobulin G; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Infant; Logistic Models; Male; Mucocutaneous Lymph Node Syndrome; Platelet Aggregation Inhibitors; Prognosis; Retreatment; Retrospective Studies; Treatment Outcome | 2019 |
Kawasaki disease-related arthritis with synovial involvement.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Aspirin; Child, Preschool; Cyclosporine; Diagnosis, Differential; Female; Humans; Immunoglobulins, Intravenous; Interleukin-18; Magnetic Resonance Imaging; Mucocutaneous Lymph Node Syndrome; Synovial Membrane | 2019 |